Herbal-induced Liver Injury (HILI): How That May Impact Rx Benefit-Risk

Track:
Clinical Safety and Pharmacovigilance

Day & Time:
June 26, 4:00PM - 5:30PM

Session Number:
382

Room Number:
152

Level:
Advanced

Type:
Session

Title:
Herbal-induced Liver Injury (HILI): How That May Impact Rx Benefit-Risk

Chair(s):
Pradip K. Paul, MD,MS
Consultant
Strategic Pharmacovigilance and Risk Management , United States

Description:
Natural health products (NHP) safety plays an important role in the possible risk assessment of a compound under development or a product in the market. This important noise can be reduced, and recalibration of internal evaluation processes is needed.

This session has been developed by the Natural Health Products (NHP) Community.

Learning Objective(s):
Discuss the role of natural health products in risk assessment; Describe the importance of the internal review process.

Presentation(s) & Speaker(s):
Herbal Induced Liver Injury (HILI); Epidemiology and Regulation of the Use of Herbals
Leonard B. Seeff, MD
Consultant in Hepatology
The Hill Group, United States

Herbal-Induced Liver Injury (HILI): Overview
Victor J. Navarro, MD
Chair, Hepatology
Einstein Medical Center, United States

Rx Benefit-risk May be Impacted by Herbal-induced Organ Injury
Pradip K. Paul, MD,MS
Consultant
Strategic Pharmacovigilance and Risk Management , United States